Risk Score Generation
Mortality risk models produce time-horizon estimates from clinical and utilization data, presented with uncertainty rather than as a single number implying false precision.
Custom Software
AI Mortality Prediction Software Development
AI mortality prediction software applies machine learning to clinical, laboratory, and utilization data to estimate short-term mortality risk, supporting clinician-initiated goals of care conversations and care planning. It functions as decision support only: no referral, treatment limitation, or care decision is ever automated, and the clinician decides everything.
Mortality prediction is the most ethically demanding category of clinical AI, because a score can influence how much treatment a patient is offered. Taction Software builds AI mortality prediction systems under governance designed for that risk, where scores prompt conversations rather than shape resource decisions, and where equity validation is non-negotiable.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Mortality Prediction Software
AI mortality prediction refers to machine learning applied to vital signs, laboratory values, diagnosis history, functional status, and utilization patterns to estimate mortality risk over a defined horizon. The legitimate clinical use is prompting timely goals of care discussion, advance care planning, and palliative involvement where appropriate. The illegitimate uses are resource allocation and treatment limitation, and we do not build those. Every decision stays with the clinician and patient. This work sits inside our broader healthcare AI practice.
Condition-Specific Modeling
Condition-specific models for heart failure, oncology, renal, and respiratory populations perform better than general models, since trajectory differs substantially between diseases.
Care Conversation Prompts
Scores generate goals of care prompts for the attending clinician, who decides whether and how to open a conversation with the patient and family.
Advance Care Planning Support
Tooling surfaces existing directives and gaps, supporting advance care planning documentation without inferring or suggesting what a patient should choose.
Palliative Referral Workflow
Where appropriate, prompts support referral, connecting with palliative care AI workflows. Referral decisions are always made by the clinician.
Prohibited Use Boundaries
We do not build resource allocation or treatment limitation configurations. Scores never restrict interventions, inform triage rationing, or appear in utilization review.
Core AI Mortality Prediction Services
Our AI mortality prediction services cover governance design, data assembly, model development, EHR integration, and monitoring. Governance is listed first deliberately: before any modeling work, we establish with your ethics and clinical leadership what the score may and may not influence, and that boundary is then enforced technically rather than by policy alone. Engagements typically open with that governance session alongside a data assessment. Deliverables are structured so ethics, palliative care, clinical leadership, and IT stakeholders can each review their portion independently.
01
Governance Framework Design
We establish use boundaries with your ethics committee first, drawing on our AI governance in healthcare work to document permitted and prohibited uses.
02
Data Assembly and Preparation
We assemble clinical, laboratory, functional, and utilization data, documenting data provenance and characterizing missingness patterns that correlate with access rather than acuity.
03
Model Development and Calibration
Development emphasizes calibration and uncertainty representation, because a mortality score presented without confidence bounds invites more certainty than the model supports.
04
EHR Integration and Presentation
Presentation design matters here. Our EHR and EMR integration practice covers score display built so no interface element reads as a recommendation to withhold care.
05
Acuity and Severity Context
Scores are contextualized alongside severity data, complementing AI patient acuity scoring so clinical context accompanies any risk figure.
06
Evaluation and Equity Monitoring
Ongoing evaluation draws on our healthcare AI evaluation services practice, with equity monitoring treated as a permanent obligation.
Benefits of AI Mortality Prediction Software
The benefits of AI mortality prediction, properly bounded, concentrate in timelier serious illness conversations and better documented advance care planning. Goals of care discussions frequently happen later than clinicians themselves would prefer, and structured prompting addresses a timing problem rather than a judgment problem. We publish no figures on mortality, length of stay, cost, or hospice utilization. Claiming benefit metrics in this domain would be both unsupportable and ethically inappropriate, since the goal is care aligned with patient wishes rather than any particular outcome.
Timelier Care Conversations
Structured prompts support serious illness conversations happening earlier, addressing a recognized timing gap rather than substituting for clinical judgment.
Better Documented Directives
Surfacing missing advance directives improves documentation completeness, so patient wishes are recorded and accessible when they matter most.
More Complete Clinical Context
Consolidated trajectory data gives clinicians longitudinal context during conversations that currently depend on reconstructing history under time pressure.
Appropriate Palliative Involvement
Timely prompts support palliative consultation where clinically appropriate, with the attending clinician deciding whether referral serves the patient.
Visible Equity Performance
Subgroup reporting makes model fairness visible across populations, which matters acutely where scores could influence how much treatment is offered.
Structured Governance Record
Complete audit logging of score generation and use creates a governance record supporting ethics committee oversight of how the tool is actually used.
Our AI Mortality Prediction Process
We deliver AI mortality prediction projects with governance ahead of engineering, which differs from our default sequence. Discovery begins with an ethics and clinical leadership session defining permitted use, prohibited use, and who may see scores. Those boundaries are then implemented technically. Development is iterative with clinical and palliative review. Deployment runs silent for an extended period, because calibration and equity in mortality modeling need more evidence before clinical exposure than most model types, and we would rather delay launch than deploy an inequitable score in this domain.
Governance and Boundary Definition
Discovery opens with an ethics review defining permitted and prohibited use, producing a documented boundary model before any development begins.
Data Assessment and Preparation
We evaluate data completeness and characterize missingness patterns, since absent data in mortality modeling often reflects access rather than clinical stability.
Model Development and Validation
Development runs to external validation where possible, reporting calibration and performance by race, insurance status, language, age, and diagnosis group.
Equity Gate Review
Models pass a mandatory equity gate with your ethics and clinical governance groups. Models showing disparate behavior are revised or abandoned rather than shipped.
Extended Silent Evaluation
Silent deployment runs longer than our standard, logging predictions against outcomes so calibration confidence is established before any clinician sees a score.
Controlled Rollout and Oversight
Rollout is gradual with ethics committee oversight, usage auditing, and continuing monitoring for the life of the deployment.
Technology and Compliance
Mortality prediction handles PHI and produces output that could, if misused, affect how much care a patient is offered. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where scores are intended to guide clinical management, SaMD classification may apply. The dominant compliance concern is equity: mortality models trained on historical data can encode differential access and treatment intensity, and a model that systematically overstates risk for a population could reduce the treatment offered to that population. We treat this as a design constraint, not a monitoring item.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
SaMD and FDA Considerations
Risk scores guiding management may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Mandatory Equity Validation
Equity validation is a hard gate. Models showing disparate calibration across race, insurance, or language are revised or abandoned rather than deployed with disclaimers.
Technical Use Restrictions
Prohibited uses are enforced technically. Scores are access restricted so utilization review and resource allocation functions cannot retrieve them at all.
Uncertainty Representation
Scores display confidence intervals rather than point estimates, since false precision in mortality prediction distorts the conversations the tool exists to prompt.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant strength here is willingness to constrain a build. We will decline configurations that use mortality scores for resource allocation, and we design technical restrictions that make prohibited use difficult rather than merely discouraged. Our leadership brings more than 20 years of personal experience in the field.
01
Governance-First Delivery
We define use boundaries with your ethics committee before development and enforce them technically, rather than documenting intentions in a policy nobody consults.
02
Willingness to Constrain Scope
We decline prohibited configurations including resource allocation and treatment limitation uses, which is a meaningful commitment rather than a marketing statement.
03
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow and governance.
04
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means EHR integration and careful score presentation are handled by engineers with clinical systems experience.
05
Equity Validation Practice
We treat subgroup validation as a hard gate rather than a monitoring afterthought, which is essential where scores could influence treatment intensity.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Pricing
AI mortality prediction pricing depends on scope, governance requirements, data condition, and validation depth. Because equity validation and extended silent evaluation are non-negotiable here, these projects carry more validation effort than comparable prediction work. We price after discovery, which includes the governance session that defines scope. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Cloud infrastructure and third-party data licensing are separate from engineering cost and itemized clearly.
MVP or Single Module
An MVP covering one condition cohort with prompt delivery typically runs $40,000 to $80,000, including governance definition and equity validation.
Full Platform Build
A full platform with condition-specific models, EHR integration, care planning workflow, and monitoring typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-facility rollout, external validation, and full governance implementation start at $200,000 and scale with facility count.
Discovery and Governance Phase
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and documented governance boundary model reviewed with your ethics committee.
Cost Drivers to Expect
Validation depth, external validation availability, condition count, and governance implementation are the largest variables, each identified during discovery for budget planning.
Ongoing Support Costs
Post-launch equity monitoring, recalibration, usage auditing, and support are quoted separately as a retainer sized to your facility count and oversight cadence.
Get Started
If you are evaluating AI mortality prediction to support timelier goals of care conversations and advance care planning, the fastest next step is a discovery call including your ethics and clinical governance stakeholders. We will define use boundaries first, then return an itemized, fixed-scope estimate with an equity validation plan. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Health systems evaluating AI mortality prediction raise ethical concerns before technical ones, which is appropriate. The answers below address what the score may influence, how equity is handled, and what we will not build. If your organization is considering any use beyond prompting clinician-led conversations, that should be discussed explicitly before scoping.
No, and we build technical restrictions to prevent it. Scores are access restricted so utilization review and resource allocation functions cannot retrieve them. The legitimate use is prompting clinician-led goals of care conversations. We decline engagements that would use mortality scores to limit or allocate treatment.
As a hard gate rather than monitoring. Historical data encodes differential access and treatment intensity, so a model can overstate risk for populations that historically received less care. We report calibration by race, insurance, and language before deployment, and abandon models showing disparate behavior rather than shipping with disclaimers.
No. It surfaces prompts for the attending clinician, who decides whether a conversation or referral serves the patient. Automated referral triggering removes clinical judgment from a decision that requires it, so we do not build it regardless of how the request is framed.
An MVP or single condition model runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments start at $200,000. These carry more validation effort than comparable prediction projects because equity validation and extended silent evaluation are not optional here.
Because calibration and equity confidence require more evidence when a score could influence treatment intensity. We run silent evaluation longer than our standard, and we would rather delay launch than expose clinicians to a score whose subgroup behavior is not yet well characterized.
Your ethics committee, palliative care leadership, and clinical governance group alongside IT, because the boundary questions matter more than the technical ones. We open discovery with a governance session rather than a data review, which is deliberately different from how we scope other prediction work.